[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.175.236. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Quick Uptakes
August 25, 1999

Tamoxifen Resistance

Author Affiliations
 

Not Available

Not Available

JAMA. 1999;282(8):723. doi:10.1001/jama.282.8.723

For years, clinicians have known that the breast cancer drug tamoxifen works by blocking the effects of estrogen in breast tissue. But they could only guess why the drug was effective for just about 5 years.

In the July 30 issue of Science, researchers from Duke University Medical Center and Novalon Pharmaceutical Corp offer an explanation. In laboratory studies, they found that tamoxifen causes estrogen receptors in the breast to change shape. The receptors form a unique pocket shape where proteins inside the cell begin to bind to the receptor. The binding action causes the cells to respond differently to tamoxifen, viewing the drug as if it were an estrogen rather than an antiestrogen, and cancer growth recurs.

First Page Preview View Large
First page PDF preview
First page PDF preview
×